Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicoletta Botto

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Trends in Cardiovascular Medicine|October 3, 2003
DNA damage as a new emerging risk factor in atherosclerosisMaria Grazia Andreassi, Nicoletta Botto
Cell Cycle (Georgetown, Tex.)|May 8, 2003
Genetic instability, DNA damage and atherosclerosisMaria Grazia Andreassi, Nicoletta Botto
Clinical Chemistry and Laboratory Medicine|May 10, 2006
Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screeningMaria Grazia Andreassi, Nicoletta Botto, Silvia Maffei
International Journal of Cardiology|October 9, 2007
A case report of myocardial infarction in young patient with a parental history of premature cardiovascular death: combination of prothrombotic gene mutationsNicoletta Botto, Massimiliano Mariani, Samantha Manfredi, et al.
Current Pharmaceutical Design|November 24, 2012
Molecular markers of cardiovascular damage in hypertensionChiara Armani, Nicoletta Botto, Maria Grazia Andreassi, et al.
Journal of Cardiology Cases|December 15, 2018
Deep venous thromboembolism after a trauma in a football player double heterozygous for factor V Leiden and prothrombin G20210A mutation: The role of genetic testing in sportNicoletta Botto, Emilio Pasanisi, Vlad Chubuchny, et al.
Coronary Artery Disease|April 19, 2003
Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery diseaseCristina Vassalle, Nicoletta Botto, Maria Grazia Andreassi, et al.
Environmental and Molecular Mutagenesis|May 25, 2013
Development of a new multiplex quantitative real-time PCR assay for the detection of the mtDNA(4977) deletion in coronary artery disease patients: a link with telomere shorteningLaura Sabatino, Nicoletta Botto, Andrea Borghini, et al.
Recenti Progressi in Medicina|September 4, 2009
[Patent foramen ovale: "les liaisons dangereuses" between anatomy and genetics]Nicoletta Botto, Lamia Ait-Ali, Rosa Sicari, et al.
Cardiovascular Ultrasound|December 23, 2008
Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathiesMaria Giovanna Colombo, Nicoletta Botto, Simona Vittorini, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Trends in Cardiovascular Medicine|October 3, 2003
DNA damage as a new emerging risk factor in atherosclerosisMaria Grazia Andreassi, Nicoletta Botto
Cell Cycle (Georgetown, Tex.)|May 8, 2003
Genetic instability, DNA damage and atherosclerosisMaria Grazia Andreassi, Nicoletta Botto
Clinical Chemistry and Laboratory Medicine|May 10, 2006
Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screeningMaria Grazia Andreassi, Nicoletta Botto, Silvia Maffei
International Journal of Cardiology|October 9, 2007
A case report of myocardial infarction in young patient with a parental history of premature cardiovascular death: combination of prothrombotic gene mutationsNicoletta Botto, Massimiliano Mariani, Samantha Manfredi, et al.
Current Pharmaceutical Design|November 24, 2012
Molecular markers of cardiovascular damage in hypertensionChiara Armani, Nicoletta Botto, Maria Grazia Andreassi, et al.
Journal of Cardiology Cases|December 15, 2018
Deep venous thromboembolism after a trauma in a football player double heterozygous for factor V Leiden and prothrombin G20210A mutation: The role of genetic testing in sportNicoletta Botto, Emilio Pasanisi, Vlad Chubuchny, et al.
Coronary Artery Disease|April 19, 2003
Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery diseaseCristina Vassalle, Nicoletta Botto, Maria Grazia Andreassi, et al.
Environmental and Molecular Mutagenesis|May 25, 2013
Development of a new multiplex quantitative real-time PCR assay for the detection of the mtDNA(4977) deletion in coronary artery disease patients: a link with telomere shorteningLaura Sabatino, Nicoletta Botto, Andrea Borghini, et al.
Recenti Progressi in Medicina|September 4, 2009
[Patent foramen ovale: "les liaisons dangereuses" between anatomy and genetics]Nicoletta Botto, Lamia Ait-Ali, Rosa Sicari, et al.
Cardiovascular Ultrasound|December 23, 2008
Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathiesMaria Giovanna Colombo, Nicoletta Botto, Simona Vittorini, et al.
Pageof 6